Search research articles
Contact Us
Filters
Showing results (301-310 of 359) with videos related to
Page
of 36
Sort By:
Annals of Hematology
|
August 29, 2020
Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network
Wolfgang Füreder, W R Sperr, S Heibl, et al.
European Journal of Clinical Investigation
|
August 31, 2007
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy
K J Aichberger, S Herndlhofer, H Agis, et al.
Journal of Hepatology
|
March 22, 2014
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
Sylvie Deuffic-Burban, Michaël Schwarzinger, Dorothée Obach, et al.
Leukemia Research Reports
|
March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H
Peter Valent, Katharina Blatt, Gregor Eisenwort, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2009
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial
Catherine Cordonnier, Cécile Pautas, Sébastien Maury, et al.
Annals of Hematology
|
May 10, 2003
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes
A Berer, E Jäger, V Sagaster, et al.
Haematologica
|
October 14, 2011
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin
Harald Herrmann, Sabine Cerny-Reiterer, Karoline V Gleixner, et al.
Wiener Klinische Wochenschrift
|
April 29, 1998
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis
F Wimazal, S Walchshofer, M Baghestanian, et al.
Bioconjugate Chemistry
|
August 28, 2013
Reversible biofunctionalization of surfaces with a switchable mutant of avidin
Philipp Pollheimer, Barbara Taskinen, Andreas Scherfler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study
K Laczika, M Novak, B Hilgarth, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 359) with videos related to
Sort By:
Page
of 36
Annals of Hematology
|
August 29, 2020
Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network
Wolfgang Füreder, W R Sperr, S Heibl, et al.
European Journal of Clinical Investigation
|
August 31, 2007
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy
K J Aichberger, S Herndlhofer, H Agis, et al.
Journal of Hepatology
|
March 22, 2014
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
Sylvie Deuffic-Burban, Michaël Schwarzinger, Dorothée Obach, et al.
Leukemia Research Reports
|
March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H
Peter Valent, Katharina Blatt, Gregor Eisenwort, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2009
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial
Catherine Cordonnier, Cécile Pautas, Sébastien Maury, et al.
Annals of Hematology
|
May 10, 2003
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes
A Berer, E Jäger, V Sagaster, et al.
Haematologica
|
October 14, 2011
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin
Harald Herrmann, Sabine Cerny-Reiterer, Karoline V Gleixner, et al.
Wiener Klinische Wochenschrift
|
April 29, 1998
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis
F Wimazal, S Walchshofer, M Baghestanian, et al.
Bioconjugate Chemistry
|
August 28, 2013
Reversible biofunctionalization of surfaces with a switchable mutant of avidin
Philipp Pollheimer, Barbara Taskinen, Andreas Scherfler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study
K Laczika, M Novak, B Hilgarth, et al.
Page
of 36